– Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer
– Targeting of Aberrant avß6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells
– Masked Chimeric Antigen Receptor for Tumor-Specific Activation
– Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma
En auge la manipulación genética de linfocitos T
En la sección: Inmunidad tumoral, Inmunoterapia, Linfocitos T. Publicado en: . 
Haga un comentario